Annette Idler is the Director of the Global Security Programme and Senior Research Fellow at the Department of Politics and International Relations, University of Oxford. She is also Visiting Scholar at Harvard University's Weatherhead Center for International Affairs.

Juan Carlos Garzón Vergara is Global Fellow at the Wilson Center and a research associate at Fundación Ideas para la Paz (Colombia).

"This exceptional collection offers a surprisingly comprehensive survey of the war on drugs five decades after it was launched, using a shared lexicon and an analytic template permitting comparison across regions." -- J. C. Hickman, CHOICE

"A comprehensive and timely assessment which consolidates the various strands of the drug policy debate from both security and development perspectives. Engaging with regions which have not been thoroughly investigated, it is innovative, ambitious and original."-- Sasha Jesperson, research analyst, Royal United Services Institute, and author of Militarized Responses to Transnational Organized Crime: The War on Crime

"With important analyses, plausible theoretical insights, and a multifaceted assessment of the current "state of play," this book is a valuable contribution to the literature. Required reading for those wishing to acquire a comprehensive view of the current International Drug Control Regime." -- William B. McAllister, Chief of the Special Projects Division, State Department Office of the Historian, and author of Drug Diplomacy in the Twentieth Century

"An essential collection that not only highlights the true costs of the overly securitized global War on Drugs, but more importantly, offers urgently needed new perspectives in the debate over what could, and should, come next." -- Peter Tinti, Senior Research Fellow, Global Initiative Against Transnational Organized Crime

"An enlightening, engaging effort to unpack the complexities of policymaking on drugs and nurture collective reflection on the need for more nuanced, people-centered and development-oriented approaches to drug policies. A must-read in a critical moment for the drug policy debate and beyond."-- Deborah Alimi, independent consultant, Daleth Research, and researcher, Université Paris 1 Panthéon Sorbonne